$10 mil Zicam biz goes to Kovel/Fuller

Published on .

Gel Tech has tapped Kovel/Fuller, Los Angeles, for its $10 million account for Zicam, a preventative common cold nasal spray. Other competitors in the review included Ground Zero, Marina del Rey, and WongDoody and Colby Effler & Partners, both Santa Monica.

Copyright June 1999, Crain Communications Inc.

Most Popular
In this article: